Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 2A receptor (5-HT2A) is a G protein-coupled receptor that mediates excitatory neurotransmission in the central nervous system. It is involved in various physiological functions, including learning, memory, mood regulation, and perception. The receptor is implicated in psychiatric disorders such as depression and schizophrenia and is a target for psychedelic drugs, antipsychotics, and antidepressants. Activation by agonists leads to increased intracellular calcium and PKC activation, while antagonists block the receptor and prevent serotonin binding.
Agonists (e.g., LSD, psilocybin) activate the receptor, leading to increased intracellular calcium and PKC activation. Antagonists (e.g., atypical antipsychotics) block the receptor, preventing serotonin binding and downstream signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT2A (5-HT2A).